{"type":"img","src":"https://cdn.quv.kr/awk93rmdy%2Fup%2F5c32ea85dae40_1920.png","height":90}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Noto Sans KR","Nanum Barun Gothic"]}
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/awk93rmdy%2Fup%2F5c32ea85dae40_1920.png","height":50}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • New Drug Candidate for Dry Eye syndrome

    RCI 001

    RCI001

     

     

    강력한 항염증 작용의 건조안 치료제 후보 물질

     

    ▪ 국내 용도 특허 10-1816277, 미국 특허출원 10-675294

    ▪ 국내 기술이전: 한림제약

    ▪ 임상 2상 이후 해외 L/O 목표

    ▪ 국내임상 1상: 2022 3Q

    ▪ 미국 FDA 임상 2상: 2022 4Q

     

    {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR","Jeju Gothic"]}{"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR","Jeju Gothic"]}
    {"google":[],"custom":["Noto Sans KR","Jeju Gothic"]}